Atrial natriuretic peptide expression is increased in rat cerebral cortex following spreading depression: Possible contribution to SD-induced neuroprotection

Neuroscience

Volumn 118, Issue 3, 2003, Pages 715-726

  Wiggins, A K ^a   Shen, P J ^a   Gundlach, A L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cyclic GMP; In situ hybridisation; Molecular plasticity; Particulate guanylate cyclase; Preconditioning; Radioimmunoassay and immunohistochemistry

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; MESSENGER RNA; NITRIC OXIDE; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; RADIOIMMUNOASSAY; RAT; RNA ANALYSIS; SIGNAL TRANSDUCTION; SPREADING CORTICAL DEPRESSION; TIME;

EID: 0037466761     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00006-X     Document Type: Article

References (99)

1. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signal in histochemical stains. J Histochem Cytochem. 40:1992;1457-1463.
2. Alessandrini A., Namura S., Moskowitz M.A., Bonventre J.V. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA. 96:1999;12866-12869.
3. Allen G.V., Cheung R.T., Cechetto D.F. Neurochemical changes following occlusion of the middle cerebral artery in rats. Neuroscience. 68:1995;1037-1050.
4. Anand-Srivastava M.B., Sairam M.R., Cantin M. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem. 265:1990;8566-8572.
5. Arabia A.-M., Shen P.-J., Gundlach A.L. Increased striatal proenkephalin mRNA subsequent to production of spreading depression in rat cerebral cortex activation of corticostriatal pathways? Mol Brain Res. 61:1998;195-202.
6. Barger S.W., Fiscus R.R., Ruth P., Hofmann F., Mattson M.P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J Neurochem. 64:1995;2087-2096.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
8. Brown J., Czarnecki A. Distribution of atrial natriuretic peptide receptor subtypes in rat brain. Am J Physiol. 258:1990;R1078-R1083.
9. Brown J., Zuo Z. Natriuretic peptide receptors are expressed during cerebral growth in the fetal rat. Am J Physiol. 269:1995;R261-R273.
10. Brown J., Zuo Z. Natriuretic peptide receptors in fetal rat. Am J Physiol. 269:1995;E12-E19.
11. Burazin T.C.D., Gundlach A.L. Rapid but transient increases in cholecystokinin mRNA levels in cerebral cortex following amygdaloid-kindled seizures in the rat. Neurosci Lett. 209:1996;65-68.
12. Burazin T.C.D., Larm J.A., Ryan M.C., Gundlach A.L. Galanin-R1 and -R2 receptor mRNA expression during development of rat brain suggests differential subtype involvement in synaptic transmission and plasticity. Eur J Neurosci. 12:2000;2901-2917.
13. Caggiano A.O., Kraig R.P. Neuronal nitric oxide synthase expression is induced in neocortical astrocytes after spreading depression. J Cereb Blood Flow Metab. 18:1998;75-87.
14. Choudhuri R., Cui L., Yong C.S.B., Klein R., Welch K., Berman N. Cortical spreading depression and gene regulation relevance to migraine . Ann Neurol. 51:2002;499-506.
15. de Vente J., Bol J.G.J.M., Steinbusch H.W.M. cGMP-producing, atrial natriuretic factor-responding cells in the rat brain. Eur J Neurosci. 1:1989;436-460.
16. de Vente J., Hopkins D.A., Markerink-Van Ittersum M., Emson P.C., Schmidt H.H.H.W., Steinbusch H.W.M. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience. 87:1998;207-241.
17. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischemic stroke an intergrated view . Trends Neurosci. 22:1999;391-397.
18. Eiden L., Mezey E., Eskay R., Beinfeld M., Palkovits M. Neuropeptide content and connectivity of the rat claustrum. Brain Res. 523:1990;245-250.
19. Farinelli S.E., Friedman W.J., Greene L.A. Natriuretic peptides prevent the death of trophic factor-deprived PC-12 cells and promote survival of basal forebrain cholinergic neurons. Soc Neurosci Abstr. 22:1996;1485.
20. Farinelli S.E., Park D.S., Greene L.A. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci. 16:1996;2325-2334.
21. Fiscus R.R., Tu A.W., Chew S.B. Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells. Neuroreport. 12:2001;185-189.
22. Forloni G., Lucca E., Angeretti N., Chiesa R., Vezzani A. Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death role of cGMP . J Neurochem. 68:1997;319-327.
23. Friedman L.K., Belayev L., Alfonso O.F., Ginsberg M.D. Distribution of glutamate and preproenkephalin messenger RNAs following transient focal cerebral ischemia. Neuroscience. 95:2000;841-857.
24. Garbers D., Lowe D. Guanylyl cyclase receptors. J Biol Chem. 269:1994;30741-30744.
25. Gibson T.R., Wildey G.M., Manaker S., Glembotski C.C. Autoradiographic localization and characterization of atrial natriuretic peptide binding sites in the rat central nervous system and adrenal gland. J Neurosci. 6:1986;2004-2011.
26. Gundlach A.L., Knobe K.E. Distribution of preproatrial natriuretic peptide mRNA in rat brain detected by in situ hybridization of DNA oligonucleotides enrichment in hypothalamic and limbic regions . J Neurochem. 59:1992;758-761.
27. Gutkowska J., Antunes-Rodrigues J., McCann S.M. Atrial natriuretic peptide in brain and pituitary gland. Physiol Rev. 77:1997;465-515.
28. Herdegen T., Sandkuhler J., Gass P., Kiessling M., Bravo R., Zimmermann M. JUN, FOS, KROX, and CREB transcription factor proteins in the rat cortex basal expression and induction by spreading depression and epileptic seizures . J Comp Neurol. 333:1993;271-288.
29. Herman J.P., Dolgas C.M., Marcinek R., Langub M.C. Jr. Expression and glucocorticoid regulation of natriuretic peptide clearance receptor (NPR-C) mRNA in rat brain and choroid plexus. J Chem Neuroanat. 11:1996;257-265.
30. Herman J.P., Dolgas C.M., Rucker D., Langub M.C. Jr. Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain. J Comp Neurol. 369:1996;165-187.
31. Herman J.P., Langub M.C. Jr, Watson R.E. Jr. Localization of C-type natriuretic peptide mRNA in rat hypothalamus. Endocrinology. 133:1993;1903-1906.
32. Hodsman G.P., Jackson B., Debrevi L.M., Ogawa K., Johnston C.I. Atrial natriuretic factor in chronic renal failure studies in man and the rat . Clin Exp Pharmacol Physiol. 14:1987;247-251.
33. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
34. Ignarro L.J. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol. 18:1991;485-490.
35. Imura H., Nakao N., Itoh H. The natriuretic peptide system in the brain implications in the central control of cardiovascular and neuroendocrine functions . Front Neuroendocrinol. 13:1992;217-249.
36. Jacobowitz D., Skofitsch G., Keiser H., Eskay R., Zamir N. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. J Comp Neurol. 157:1985;13-28.
37. Jacobs O., Van Bree L., Mailleux P., Zhang F., Schiffmann S., Halleux P., Albala N., Vanderhaeghen J.-J. Homolateral cerebrocortical increase of immediate early gene and neurotransmitter messenger RNAs after minimal cortical lesion blockade by N-methyl-D-aspartate antagonist . Neuroscience. 59:1994;827-836.
38. Kariko K., Harris V., Rangel Y., Duvall M., Welsh F. Effect of cortical spreading depression on the levels of mRNA coding for putative neuroprotection proteins in rat brain. J Cereb Blood Flow Metab. 18:1998;1308-1315.
39. Kawahara N., Ruetzler C.A., Klatzo I. Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia. Neurol Res. 17:1995;9-16.
40. Kawata M., Nakao K., Morii N., Jiso Y., Yamashita H., Imura H., Sano Y. Atrial natriuretic polypeptide topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry . Neuroscience. 16:1985;521-546.
41. Kiemer A.K., Hartung T., Vollmar A.M. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol. 165:2000;175-181.
42. Kim Y.-M., Chung H.-T., Kim S.-S., Han J.-A., Yoo Y.-M., Kim K.-M., Lee G.-H., Yun T.-H., Green A., Li J., Simmons R.L., Billiar T.R. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci. 19:1999;6740-6747.
43. Kobayashi S., Harris V.A., Welsh F.A. Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J Cereb Blood Flow Metab. 15:1995;721-727.
44. Kokaia Z., Gido G., Ringstedt T., Bengzon J., Kokaia M., Siesjo B.K., Persson H., Lindvall O. Rapid increase of BDNF mRNA levels in cortical neurons following spreading depression regulation by glutamatergic mechanisms independent of seizure activity . Mol Brain Res. 19:1993;277-286.
45. Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 252:1991;120-124.
46. Komatsu Y., Nakao K., Suga S.-I., Ogawa Y., Mukoyama M., Arai H., Shirakami G., Hosoda K., Nakagawa O., Hama N., Kishimoto I., Imura H. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 129:1991;1104-1106.
47. Koponen S., Keinanen R., Roivainen T., Hirvonen T., Narhi M., Chan P.H., Koistinaho J. Spreading depression induces expression of calcium-independent protein kinase C subspecies in ischaemia-sensitive cortical layers regulation by N-methyl-D-aspartate receptors and glucocorticoids . Neuroscience. 93:1999;985-993.
48. Langub M.C. Jr, Watson R.E. Jr, Herman J.P. Distribution of natriuretic peptide precursor mRNAs in the rat brain. J Comp Neurol. 356:1995;189-199.
49. Leao A.A.P. Spreading depression activity in the cerebral cortex. J Neurophysiol. 7:1944;359-390.
50. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med. 339:1998;321-328.
51. Maki M., Takayanagi R., Misono K., Padney K., Tibbetts C., Inagami T. Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence. Nature. 309:1984;722-724.
52. Mantyh C.R., Kruger L., Brecha N.C., Mantyh P.W. Localization of specific binding sites for atrial natriuretic factor in the central nervous system of rat, guinea pig, cat and human. Brain Res. 412:1987;329-342.
53. Markerink-Van Ittersum M., Steinbusch H.W.M., de Vente J. Region-specific developmental patterns of atrial natriuretic factor- and nitric oxide-activated guanylyl cyclases in the postnatal frontal rat brain. Neuroscience. 78:1997;571-587.
54. Matsushima K., Hogan M.J., Hakim A.M. Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 16:1996;221-226.
55. Mattson M., Guo Z., Geiger J. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem. 73:1999;532-537.
56. McKenzie J.C., Berman N.E., Thomas C.R., Young J.K., Compton L.Y., Cothran L.N., Liu W.L., Klein R.M. Atrial natriuretic peptide-like (ANP-LIR) and ANP prohormone immunoreactive astrocytes and neurons of the human cerebral cortex. Glia. 12:1994;228-243.
57. Mies G., Iijima T., Hossmann K.A. Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat. Neuroreport. 4:1993;709-711.
58. Moro M., Fernandez-Tome P., Leza J., Lorenzo P., Lizasoain I. Neuronal death induced by SIN-1 in the presence of superoxide dismutase protection by cyclic GMP . Neuropharmacology. 37:1998;1071-1079.
59. Namura S., Iihara K., Takami S., Nagata I., Kikuchi H., Matsushita K., Moskowitz M.A., Bonventre J.V. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci USA. 98:2001;11569-11574.
60. Nedergaard M., Hansen A.J. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res. 449:1988;395-398.
61. Nogami M., Shiga J., Takatsu A., Endo N., Ishiyama I. Immunohistochemistry of atrial natriuretic peptide in brain infarction. J Histochem. 33:2001;87-90.
62. Ogawa K., Smith A.I., Hodsman G.P., Jackson B., Woodcock E.A., Johnston C.I. Plasma atrial natriuretic peptide concentrations and circulating forms in normal man and patients with chronic renal failure . Clin Exp Pharmacol Physiol. 14:1987;95-102.
63. Olenik C., Lais A., Meyer D. Effects of unilateral cortex lesions on gene expression of rat cortical cholecystokinin neurons. Mol Brain Res. 10:1991;259-265.
64. O'Shea R.D., Gundlach A.L. Quantitative analysis of in situ hybridization histochemistry. Wisden W., Morris B.J. In situ hybridization protocols for the brain. 1994;57-78 Academic Press, London.
65. Pan J.T., Lai C.J., Yen S.H. Effects of natriuretic peptides and dopamine on single-unit activity of dorsomedial arcuate neurons in rat brain slices. Brain Res. 737:1996;78-82.
66. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. 2nd edn. Sydney: Academic Press.
67. Potter L.R., Hunter T. Guanylyl cyclase-linked natriuretic peptide receptors structure and regulation . J Biol Chem. 276:2001;6057-6060.
68. Potter L.R., Garbers D.L. Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J Biol Chem. 267:1992;14531-14534.
69. Prins B.A., Weber M.J., Hu R.-M., Pedram A., Daniels M., Levin E.R. Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor potential role in the inhibition of astrocyte proliferation . J Biol Chem. 271:1996;14156-14162.
70. Quirion R., Dalpe M., Dam T.V. Characterization and distribution of receptors for the atrial natriuretic peptides in mammalian brain. Proc Natl Acad Sci USA. 83:1986;174-178.
71. Rauca C., Schafer K., Hollt V. Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat. Naunyn Schmiedeberg's Arch Pharmacol. 306:1999;633-638.
72. Read S.J., Hirst W.D., Upton N., Parsons A.A. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SD-220453) but not sumatriptan. Brain Res. 891:2001;69-77.
73. Richard D., Bourque C.W. Atrial natriuretic peptide modulates synaptic transmission from osmoreceptor afferents to the supraoptic nucleus. J Neurosci. 16:1996;7526-7532.
74. Ryan M.C., Gundlach A.L. Anatomical localisation of preproatrial natriuretic peptide mRNA in the rat brain by in situ hybridization histochemistry novel identification in olfactory regions . J Comp Neurol. 356:1995;168-182.
75. Ryan M.C., Gundlach A.L. Differential regulation of angiotensinogen and natriuretic peptide mRNAs in rat brain by osmotic stimulation focus on anterior hypothalamus and supraoptic nucleus . Peptides. 18:1997;1365-1375.
76. Ryan M.C., Gundlach A.L. Ontogenic expression of natriuretic peptide mRNAs in postnatal rat brain implications for development? Dev Brain Res. 105:1998;251-268.
77. Ryan M.C., Shen P.-J., Gundlach A.L. Angiotensinogen and natriuretic peptide mRNAs in rat brain localization and differential regulation by adrenal steroids in hypothalamus . Peptides. 18:1997;495-504.
78. Saper C.B., Standaert D.G., Currie M.G., Schwartz D., Geller D.M., Needleman P. Atriopeptin-immunoreactive neurons in the brain presence in cardiovascular regulatory areas . Science. 227:1985;1047-1049.
79. Shen P.-J., Gundlach A.L. Differential increases in chromogranins, but not synapsin I, in cortical neurons following spreading depression implications for functional roles and transmitter peptide release . Eur J Neurosci. 10:1998;2217-2230.
80. 1B-adrenoceptors . Exp Neurol. 154:1998;612-627.
81. Shen P.-J., Gundlach A.L. Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD) implications for SD- and NO-mediated neuroprotection . Exp Neurol. 160:1999;317-332.
82. Skofitsch G., Jacobowitz D., Eskay R., Zamir N. Distribution of atrial natriuretic factor-like immunoreactive neurons in the rat brain. Neuroscience. 16:1985;917-948.
83. Somjen G.G., Aitken P.G., Czeh G.L., Herreras O., Jing J., Young J.N. Mechanisms of spreading depression a review of recent findings and a hypothesis . Can J Physiol Pharmacol. 70:1992;S248-254.
84. Standaert D., Cechetto D., Needleman P., Saper C. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature. 329:1987;151-153.
85. Standaert D.G., Needleman P., Day M.L., Weigand R., Krause J.E. Expression of the gene for preproatriopeptin in the central nervous system of the rat. Brain Res. 464:1988;7-13.
86. Suga S.-I., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K., Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 130:1992;229-239.
87. Tsukagoshi H., Shimizu Y., Kawata T., Hisada T., Shimizu Y., Iwamae S., Ishizuka T., Iizuka K., Dobashi K., Mori M. Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation. Regul Pept. 99:2001;21-29.
88. Vaillancourt P., Omer S., Palfree R., Varma D.R., Mulay S. Downregulation of adrenal atrial natriuretic peptide receptor mRNAs and proteins by pregnancy in rats. J Endocrinol. 155:1997;523-530.
89. Van Bree L., Zhang F., Schiffmann S.N., Halleux P., Mailleux P., Vanderhaeghen J.-J. Homolateral cerebrocortical changes in neuropeptide and receptor expression after minimal cortical infarction. Neuroscience. 69:1995;847-858.
90. Vezzani A., Hoyer D. Brain somatostatin a candidate inhibitory role in seizures and epileptogenesis . Eur J Neurosci. 11:1999;3767-3776.
91. Világi I., Klapka N., Luhmann H.J. Optical recording of spreading depression in rat neocortical slices. Brain Res. 898:2001;288-296.
92. Vollmar A.M., Schulz R. Gene expression and secretion of atrial natriuretic peptide by murine macrophages. J Clin Invest. 94:1994;539-545.
93. Wang X., Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signalling in the nervous system. J Neurochem. 68:1997;443-456.
94. Wisden W., Morris B.J. In situ hybridization with synthetic oligonucleotide probes. Wisden W., Morris B.J. In situ hybridization protocols for the brain. 1994;9-34 Academic Press, London.
95. Yanomoto H., Hashimoto N., Nagata I., Kikuchi H. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain. Brain Res. 784:1998;239-249.
96. B receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rat hippocampal slices. Neurosci Lett. 191:1995;99-102.
97. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., Pleasure D. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J Neurochem. 74:2000;633-640.
98. Zamir N., Skofitsch G., Eskay R.L., Jacobowitz D.M. Distribution of immunoreactive atrial natriuretic peptides in the central nervous system of the rat. Brain Res. 365:1986;105-111.
99. Zoli M., Grimaldi R., Ferrari R., Zini I., Agnati L.F. Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats. Stroke. 28:1997;1049-1058.